Biochemistry, Genetics and Molecular Biology
Cancer Cell
58%
Anthracycline
58%
Clinical Trial
27%
Gene Expression Profiling
26%
Transcriptomics
26%
Anticancer
23%
Oxidoreductase
23%
Escherichia coli
23%
Flavodoxin
23%
Gene Expression
21%
Chromosome Instability
18%
Genomics
17%
Cell Growth
17%
Immunoreactivity
17%
TOP2A
16%
Genetics
15%
Receptor Tyrosine Kinase
15%
Small Molecule
14%
Nicotinamide Adenine Dinucleotide Phosphate
13%
Epidermal Growth Factor Receptor
13%
RNA Sequence
12%
Gene Signature
11%
Glycogen Synthase Kinase 3
11%
Wild Type
11%
Metabolic Pathway
11%
Telomerase
11%
5-HT Receptor
11%
Cell Cycle
11%
Antimetabolite
11%
Ribonucleoprotein
11%
Autophagy
11%
Brain-Derived Neurotrophic Factor
11%
Phosphotransferase
11%
Kinase
11%
Binding Site
11%
Drug Tolerability
11%
Patient Coding
11%
Estrogen Receptor
11%
Reverse Transcriptase
11%
FKBP5
11%
Structure Activity Relation
11%
Macrophage
11%
Electron Transfer
11%
FLT1
11%
Methotrexate
11%
Pharmacogenomics
11%
Fluorouracil
11%
Cyclin D1
11%
Cytokine
11%
Recurrence Free Survival
9%
Medicine and Dentistry
Breast Cancer
100%
Neoplasm
38%
Anthracycline
34%
Cancer Cell
25%
Estrogen Receptor
23%
Biological Marker
23%
Recurrence Free Survival
20%
Chromosomal Instability
18%
Clinical Trial
15%
Transcriptomics
15%
Gene Expression Profiling
14%
Diseases
14%
Cell Signaling Pathway
14%
Recurrent Disease
13%
Metastatic Carcinoma
13%
In Vitro
13%
Osmium Derivative
11%
Esophageal Adenocarcinoma
11%
Cytokine Signaling
11%
Krukenberg Tumor
11%
Nerve Cell Adhesion Molecule
11%
Hormone Therapy
11%
Virus Transmission
11%
MEK Inhibitor
11%
Serotonin Receptor
11%
Hepatitis C Virus
11%
Protein-Protein Interaction
11%
Macrophage
11%
Melanoma
11%
Uvomorulin
11%
Breast Carcinoma
11%
Cell Cycle
11%
Esophageal Cancer
11%
Health Care Cost
11%
Ligation
11%
Phenotypic Screening
11%
Ionophore
11%
Trametinib
11%
Overall Survival
9%
RNA Sequencing
9%
Mesenchymal-Epithelial Transition
9%
Breast Tumor
9%
Predictive Marker
8%
Reactive Oxygen Species
7%
DNA Damage
7%
Time Series Analysis
7%
Cancer Therapy
7%
Gamma Urogastrone
7%
Epidermal Growth Factor Receptor 2
7%
Tamoxifen
7%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
72%
Anthracycline
34%
Epirubicin
24%
Methotrexate
20%
Cyclophosphamide
20%
Fluorouracil
20%
Chemotherapy
19%
Chromosomal Instability
18%
Cancer Chemotherapy
17%
Malignant Neoplasm
16%
Clinical Trial
15%
Neoplasm
14%
Pharmacogenomics
14%
Tolerability
11%
Hepatitis C Virus
11%
Serotonin Receptor
11%
Virus Transmission
11%
Cytokine
11%
Nerve Cell Adhesion Molecule
11%
Osmium Derivative
11%
Melanoma
11%
Estrogen Receptor
11%
Polycyclic Aromatic Hydrocarbon
11%
Protein Tyrosine Kinase
11%
Tissue Inhibitor of Metalloproteinase 1
11%
Uvomorulin
11%
Biological Marker
10%
Recurrence Free Survival
8%
Diseases
6%
Protein Microarrays
5%
Antiproliferative Activity
5%
Cisplatin
5%
Triple Negative Breast Cancer
5%
Reactive Oxygen Metabolite
5%
Protein P53
5%
Ovary Cancer
5%
Cancer Model
5%
Phosphotransferase
5%
Anticancer Drug
5%
Antioxidant
5%
Metal Complex
5%
RNA-Sequencing
5%
Iridium Complex
5%
